Cargando…

Effects of intensified conditioning on Epstein-Barr virus and cytomegalovirus infections in allogeneic hematopoietic stem cell transplantation for hematological malignancies

BACKGROUND: Intensified conditioning regimens (increasing the intensity of standard myeloablative conditioning) for hematological malignancies in allogeneic hematopoietic stem cell transplantation (allo-HSCT) could reduce the relapse rate of the underlying disease, but it might simultaneously increa...

Descripción completa

Detalles Bibliográficos
Autores principales: Xuan, Li, Huang, Fen, Fan, Zhiping, Zhou, Hongsheng, Zhang, Xian, Yu, Guopan, Zhang, Yu, Liu, Can, Sun, Jing, Liu, Qifa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3422173/
https://www.ncbi.nlm.nih.gov/pubmed/22856463
http://dx.doi.org/10.1186/1756-8722-5-46
_version_ 1782241004483510272
author Xuan, Li
Huang, Fen
Fan, Zhiping
Zhou, Hongsheng
Zhang, Xian
Yu, Guopan
Zhang, Yu
Liu, Can
Sun, Jing
Liu, Qifa
author_facet Xuan, Li
Huang, Fen
Fan, Zhiping
Zhou, Hongsheng
Zhang, Xian
Yu, Guopan
Zhang, Yu
Liu, Can
Sun, Jing
Liu, Qifa
author_sort Xuan, Li
collection PubMed
description BACKGROUND: Intensified conditioning regimens (increasing the intensity of standard myeloablative conditioning) for hematological malignancies in allogeneic hematopoietic stem cell transplantation (allo-HSCT) could reduce the relapse rate of the underlying disease, but it might simultaneously increase the transplant-related mortality including the mortality of infections. To explore whether intensified conditioning affected Epstein-Barr virus (EBV) and cytomegalovirus (CMV) infections, 185 patients undergoing allo-HSCT were enrolled. METHODS: A total of 104 cases received standard and 81 intensified conditioning. Cyclosporine A (CsA) withdrawal and/or donor lymphocyte infusion (DLI) were conducted in high-risk patients. The EBV-DNA and CMV-DNA levels of blood were monitored regularly by quantitative real-time polymerase chain reaction (RQ-PCR) and immune reconstitution of recipients were analyzed by flow cytometry. RESULTS: The 3-year cumulative incidence of EBV viremia, EBV-associated diseases and mortality of EBV-associated diseases were 25.3% ± 4.6%, 10.5% ± 3.4% and 0.0% ± 0.0% in the standard group, compared with 45.6% ± 6.5%, 26.0% ±5.3% and 7.3% ± 3.1% in the intensified group (P = 0.002, P = 0.002, P = 0.008). The 3-year cumulative incidence of CMV viremia and CMV-associated diseases, mortality of CMV-associated diseases and incidence of bacterial and fungal infections were similar between the two groups (P = 0.855, P = 0.581, P = 0.933, P = 0.142, P = 0.182, respectively). Multivariate analysis showed that intensified conditioning was one of the risk factors for EBV viremia and EBV-associated diseases (P = 0.037, P = 0.037), but it had no effects on CMV infections. The percentage of CD4(+) T cells and CD4(+)/CD8(+) ratio at 3 months post-transplantation were lower in the intensified group (P = 0.032, P = 0.022). The 3-year OS and DFS in the standard group were 62.2% ± 5.8% and 60.6% ± 5.6%, compared with 51.6% ± 6.2% and 51.1% ± 5.9% in the intensified group (P = 0.029, P = 0.063). CONCLUSIONS: Intensified conditioning represents a promising approach for high-risk hematological malignancies, although it affects early immune reconstitution of recipients and increases the incidence and mortality of EBV infections.
format Online
Article
Text
id pubmed-3422173
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-34221732012-08-18 Effects of intensified conditioning on Epstein-Barr virus and cytomegalovirus infections in allogeneic hematopoietic stem cell transplantation for hematological malignancies Xuan, Li Huang, Fen Fan, Zhiping Zhou, Hongsheng Zhang, Xian Yu, Guopan Zhang, Yu Liu, Can Sun, Jing Liu, Qifa J Hematol Oncol Research BACKGROUND: Intensified conditioning regimens (increasing the intensity of standard myeloablative conditioning) for hematological malignancies in allogeneic hematopoietic stem cell transplantation (allo-HSCT) could reduce the relapse rate of the underlying disease, but it might simultaneously increase the transplant-related mortality including the mortality of infections. To explore whether intensified conditioning affected Epstein-Barr virus (EBV) and cytomegalovirus (CMV) infections, 185 patients undergoing allo-HSCT were enrolled. METHODS: A total of 104 cases received standard and 81 intensified conditioning. Cyclosporine A (CsA) withdrawal and/or donor lymphocyte infusion (DLI) were conducted in high-risk patients. The EBV-DNA and CMV-DNA levels of blood were monitored regularly by quantitative real-time polymerase chain reaction (RQ-PCR) and immune reconstitution of recipients were analyzed by flow cytometry. RESULTS: The 3-year cumulative incidence of EBV viremia, EBV-associated diseases and mortality of EBV-associated diseases were 25.3% ± 4.6%, 10.5% ± 3.4% and 0.0% ± 0.0% in the standard group, compared with 45.6% ± 6.5%, 26.0% ±5.3% and 7.3% ± 3.1% in the intensified group (P = 0.002, P = 0.002, P = 0.008). The 3-year cumulative incidence of CMV viremia and CMV-associated diseases, mortality of CMV-associated diseases and incidence of bacterial and fungal infections were similar between the two groups (P = 0.855, P = 0.581, P = 0.933, P = 0.142, P = 0.182, respectively). Multivariate analysis showed that intensified conditioning was one of the risk factors for EBV viremia and EBV-associated diseases (P = 0.037, P = 0.037), but it had no effects on CMV infections. The percentage of CD4(+) T cells and CD4(+)/CD8(+) ratio at 3 months post-transplantation were lower in the intensified group (P = 0.032, P = 0.022). The 3-year OS and DFS in the standard group were 62.2% ± 5.8% and 60.6% ± 5.6%, compared with 51.6% ± 6.2% and 51.1% ± 5.9% in the intensified group (P = 0.029, P = 0.063). CONCLUSIONS: Intensified conditioning represents a promising approach for high-risk hematological malignancies, although it affects early immune reconstitution of recipients and increases the incidence and mortality of EBV infections. BioMed Central 2012-08-02 /pmc/articles/PMC3422173/ /pubmed/22856463 http://dx.doi.org/10.1186/1756-8722-5-46 Text en Copyright ©2012 Xuan et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Xuan, Li
Huang, Fen
Fan, Zhiping
Zhou, Hongsheng
Zhang, Xian
Yu, Guopan
Zhang, Yu
Liu, Can
Sun, Jing
Liu, Qifa
Effects of intensified conditioning on Epstein-Barr virus and cytomegalovirus infections in allogeneic hematopoietic stem cell transplantation for hematological malignancies
title Effects of intensified conditioning on Epstein-Barr virus and cytomegalovirus infections in allogeneic hematopoietic stem cell transplantation for hematological malignancies
title_full Effects of intensified conditioning on Epstein-Barr virus and cytomegalovirus infections in allogeneic hematopoietic stem cell transplantation for hematological malignancies
title_fullStr Effects of intensified conditioning on Epstein-Barr virus and cytomegalovirus infections in allogeneic hematopoietic stem cell transplantation for hematological malignancies
title_full_unstemmed Effects of intensified conditioning on Epstein-Barr virus and cytomegalovirus infections in allogeneic hematopoietic stem cell transplantation for hematological malignancies
title_short Effects of intensified conditioning on Epstein-Barr virus and cytomegalovirus infections in allogeneic hematopoietic stem cell transplantation for hematological malignancies
title_sort effects of intensified conditioning on epstein-barr virus and cytomegalovirus infections in allogeneic hematopoietic stem cell transplantation for hematological malignancies
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3422173/
https://www.ncbi.nlm.nih.gov/pubmed/22856463
http://dx.doi.org/10.1186/1756-8722-5-46
work_keys_str_mv AT xuanli effectsofintensifiedconditioningonepsteinbarrvirusandcytomegalovirusinfectionsinallogeneichematopoieticstemcelltransplantationforhematologicalmalignancies
AT huangfen effectsofintensifiedconditioningonepsteinbarrvirusandcytomegalovirusinfectionsinallogeneichematopoieticstemcelltransplantationforhematologicalmalignancies
AT fanzhiping effectsofintensifiedconditioningonepsteinbarrvirusandcytomegalovirusinfectionsinallogeneichematopoieticstemcelltransplantationforhematologicalmalignancies
AT zhouhongsheng effectsofintensifiedconditioningonepsteinbarrvirusandcytomegalovirusinfectionsinallogeneichematopoieticstemcelltransplantationforhematologicalmalignancies
AT zhangxian effectsofintensifiedconditioningonepsteinbarrvirusandcytomegalovirusinfectionsinallogeneichematopoieticstemcelltransplantationforhematologicalmalignancies
AT yuguopan effectsofintensifiedconditioningonepsteinbarrvirusandcytomegalovirusinfectionsinallogeneichematopoieticstemcelltransplantationforhematologicalmalignancies
AT zhangyu effectsofintensifiedconditioningonepsteinbarrvirusandcytomegalovirusinfectionsinallogeneichematopoieticstemcelltransplantationforhematologicalmalignancies
AT liucan effectsofintensifiedconditioningonepsteinbarrvirusandcytomegalovirusinfectionsinallogeneichematopoieticstemcelltransplantationforhematologicalmalignancies
AT sunjing effectsofintensifiedconditioningonepsteinbarrvirusandcytomegalovirusinfectionsinallogeneichematopoieticstemcelltransplantationforhematologicalmalignancies
AT liuqifa effectsofintensifiedconditioningonepsteinbarrvirusandcytomegalovirusinfectionsinallogeneichematopoieticstemcelltransplantationforhematologicalmalignancies